Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Pliant Therapeutics, Inc. (PLRX) had Normalized Pre-Tax Income of $-149.34M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-149.34M |
|
-- |
|
-- |
|
$156.37M |
|
$-156.37M |
|
$7.03M |
|
$-149.34M |
|
|
Normalized Pre-Tax Income |
$-149.34M |
$-149.34M |
|
$-149.34M |
|
$-149.34M |
|
$-149.34M |
|
$-156.37M |
|
$-150.72M |
|
61.37M |
|
61.37M |
|
$-2.43 |
|
$-2.43 |
|
| Balance Sheet Financials | |
$196.45M |
|
$2.94M |
|
$28.78M |
|
$225.23M |
|
$16.36M |
|
-- |
|
$27.66M |
|
$44.02M |
|
$181.21M |
|
$181.21M |
|
$181.21M |
|
61.45M |
|
| Cash Flow Statement Financials | |
$-128.34M |
|
$134.29M |
|
$-31.70M |
|
$72.67M |
|
$46.93M |
|
$-25.74M |
|
$26.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-128.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-82.42% |
|
-82.42% |
|
-66.31% |
|
-82.42% |
|
$2.95 |
|
$-2.09 |
|
$-2.09 |
|